Atlas Trials

REMS Retigabine Study

Clinical trial NCT01938560 · COMPLETED

Trial details

NCT number
NCT01938560
Sponsor
GlaxoSmithKline
Status
COMPLETED
Study type
OBSERVATIONAL
Epilepsy
Start date
2013-02-01
Primary completion
2013-05-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.